Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

Oxman, 1994, Users’ guides to the medical literature. VI. How to use an overview. Evidence-based medicine working group, JAMA, 272, 1367, 10.1001/jama.1994.03520170077040

Swingler, 2003, Number of published systematic reviews and global burden of disease: database analysis, BMJ, 327, 1083, 10.1136/bmj.327.7423.1083

2006

Young, 2005, Putting clinical trials into context, Lancet, 366, 107, 10.1016/S0140-6736(05)66846-8

Mulrow, 1987, The medical review article: state of the science, Ann Intern Med, 106, 485, 10.7326/0003-4819-106-3-485

Sacks, 1987, Meta-analysis of randomized controlled trials, New Engl J Med, 316, 450, 10.1056/NEJM198702193160806

Sacks, 1996, Meta-analysis: an update, Mt Sinai J Med, 63, 216

Moher, 1994, Improving the quality of reporting of meta-analysis of randomized controlled trials: the QUOROM statement, Lancet, 354, 1896, 10.1016/S0140-6736(99)04149-5

Green, 2005, Glossary

Strech, 2008, Value judgments in the analysis and synthesis of evidence, J Clin Epidemiol, 61, 521, 10.1016/j.jclinepi.2008.01.001

Moher, 2006, Systematic reviews: when is an update an update?, Lancet, 367, 881, 10.1016/S0140-6736(06)68358-X

University of York, Centre for Reviews and Dissemination; 2009. Available from: http://www.york.ac.uk/inst/crd/ [accessed 19 May 2009].

2008

De Angelis, 2004, Clinical trial registration: a statement from the International Committee of Medical Journal Editors, CMAJ, 171, 606, 10.1503/cmaj.1041281

Whittington, 2004, Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data, Lancet, 363, 1341, 10.1016/S0140-6736(04)16043-1

Bagshaw, 2006, Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence, Arch Intern Med, 166, 161, 10.1001/archinte.166.2.161

Biondi-Zoccai, 2006, Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study, BMJ, 332, 202, 10.1136/bmj.38693.516782.7C

Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration, PLoS Med, 6, e1000100, 10.1371/journal.pmed.1000100

Altman, 2001, The revised CONSORT statement for reporting randomized trials: explanation and elaboration, Ann Intern Med, 134, 663, 10.7326/0003-4819-134-8-200104170-00012

Bossuyt, 2003, Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD explanation and elaboration, Ann Intern Med, 138, W1, 10.7326/0003-4819-138-1-200301070-00012-w1

Vandenbroucke, 2007, Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration, Ann Intern Med, 147, W163, 10.7326/0003-4819-147-8-200710160-00010-w1

Moher, 2007, Epidemiology and reporting characteristics of systematic reviews, PLoS Med, 4, e78, 10.1371/journal.pmed.0040078

Bhandari, 2001, Meta-analyses in orthopaedic surgery: a systematic review of their methodologies, J Bone Joint Surg Am, 83-A, 15, 10.2106/00004623-200101000-00003

Kelly, 2001, Evaluating the quality of systematic reviews in the emergency medicine literature, Ann Emerg Med, 38, 518, 10.1067/mem.2001.115881

Richards, 2004, The quality of systematic reviews in dentistry, Evid Based Dent, 5, 17, 10.1038/sj.ebd.6400242

Choi, 2001, Examining the evidence in anesthesia literature: a critical appraisal of systematic reviews, Anesth Analg, 92, 700

Delaney, 2005, A systematic evaluation of the quality of meta-analyses in the critical care literature, Crit Care, 9, R575, 10.1186/cc3803

Dickersin, 2005, Publication bias: recognizing the problem, understanding its origins and scope, and preventing harm, 11

Sutton, 2005, Evidence concerning the consequences of publication and related biases, 175

Lau, 2006, The case of the misleading funnel plot, BMJ, 333, 597, 10.1136/bmj.333.7568.597

Ladabaum, 2001, Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer: a cost-effectiveness analysis, Ann Intern Med, 135, 769, 10.7326/0003-4819-135-9-200111060-00007

Deeks, 2001, Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests, BMJ, 323, 157, 10.1136/bmj.323.7305.157

Altman, 2001, Systematic reviews of evaluations of prognostic variables, BMJ, 323, 224, 10.1136/bmj.323.7306.224

Ioannidis, 2001, Replication validity of genetic association studies, Nat Genet, 29, 306, 10.1038/ng749

Lavis, 2005, Towards systematic reviews that inform health care management and policy-making, J Health Serv Res Policy, 10, 35, 10.1258/1355819054308549

Stewart, 1995, Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group, Stat Med, 14, 2057, 10.1002/sim.4780141902

Moja, 2005, Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study, BMJ, 330, 1053, 10.1136/bmj.38414.515938.8F

Guyatt, 2008, GRADE: an emerging consensus on rating quality of evidence and strength of recommendations, BMJ, 336, 924, 10.1136/bmj.39489.470347.AD

Schunemann, 2006, An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations, Am J Respir Crit Care Med, 174, 605, 10.1164/rccm.200602-197ST

Chan, 2004, Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles, JAMA, 291, 2457, 10.1001/jama.291.20.2457

Chan, 2004, Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research, CMAJ, 171, 735, 10.1503/cmaj.1041086

Silagy, 2002, Publishing protocols of systematic reviews: comparing what was done to what was planned, JAMA, 287, 2831, 10.1001/jama.287.21.2831